Literature DB >> 22935739

Effect of aerobic interval training and caffeine on blood platelet function.

Joshua P Whittaker1, Matthew D Linden, Vernon G Coffey.   

Abstract

PURPOSE: Hyperactive platelets contribute to the thrombotic response in humans, and exercise transiently increases platelet function. Caffeine is routinely used by athletes as an ergogenic aid, but the combined effect of exercise and caffeine on platelet function has not been investigated.
METHODS: Twelve healthy males were randomly assigned to one of four groups and undertook four experimental trials of a high-intensity aerobic interval training (AIT) bout or rest with ingestion of caffeine (3 mg·kg(-1)) or placebo. AIT was 8 × 5 min at approximately 75% peak power output (approximately 80% V˙O2peak) and 1-min recovery (approximately 40% peak power output, approximately 50% V˙O2peak) intervals. Blood/urine was collected before, 60, and 90 min after capsule ingestion and analyzed for platelet aggregation/activation.
RESULTS: AIT increased platelet reactivity to adenosine diphosphate (placebo 30.3%, caffeine 13.4%, P < 0.05) and collagen (placebo 10.8%, caffeine 5.1%, P < 0.05) compared with rest. Exercise placebo increased adenosine diphosphate-induced aggregation 90 min postingestion compared with baseline (40.5%, P < 0.05), but the increase when exercise was combined with caffeine was small (6.6%). During the resting caffeine protocol, collagen-induced aggregation was reduced (-4.3%, P < 0.05). AIT increased expression of platelet activation marker PAC-1 with exercise placebo (P < 0.05) but not when combined with caffeine.
CONCLUSION: A single bout of AIT increases platelet function, but caffeine ingestion (3 mg·kg(-1)) does not exacerbate platelet function at rest or in response to AIT. Our results provide new information showing caffeine at a dose that can elicit ergogenic effects on performance has no detrimental effect on platelet function and may have the potential to attenuate increases in platelet activation and aggregation when undertaking strenuous exercise.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22935739     DOI: 10.1249/MSS.0b013e31827039db

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  6 in total

1.  Mean platelet volume (MPV) predicts middle distance running performance.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Elisa Danese; Spyros Skafidas; Cantor Tarperi; Gian Cesare Guidi; Federico Schena
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

2.  Enhanced Strength and Sprint Levels, and Changes in Blood Parameters during a Complete Athletics Season in 800 m High-Level Athletes.

Authors:  Beatriz Bachero-Mena; Fernando Pareja-Blanco; Juan J González-Badillo
Journal:  Front Physiol       Date:  2017-08-31       Impact factor: 4.566

Review 3.  Exercise perspective on common cardiac medications.

Authors:  Louise Anne Dizon; Dae Yun Seo; Hyoung Kyu Kim; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Integr Med Res       Date:  2013-04-23

4.  Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial.

Authors:  Sara Mijwel; Kate A Bolam; Jacob Gerrevall; Theodoros Foukakis; Yvonne Wengström; Helene Rundqvist
Journal:  Oncologist       Date:  2019-08-07

Review 5.  Effects of Physical (In)activity on Platelet Function.

Authors:  Stefan Heber; Ivo Volf
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

Review 6.  Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper.

Authors:  Akos Koller; M Harold Laughlin; Edina Cenko; Cor de Wit; Kálmán Tóth; Raffaele Bugiardini; Danijela Trifunovits; Marija Vavlukis; Olivia Manfrini; Adam Lelbach; Gabriella Dornyei; Teresa Padro; Lina Badimon; Dimitris Tousoulis; Stephan Gielen; Dirk J Duncker
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 13.081

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.